6533b856fe1ef96bd12b2fd9

RESEARCH PRODUCT

Incidence and Clinical Impact of Right Ventricular Involvement (Biventricular Ballooning) in Takotsubo Syndrome

Francesco RomeoIrene GianniniFederico GuerraIbrahim AkinThomas StiermaierGiuseppina NovoEnrica MarianoNatale Daniele BrunettiIngo EitelIbrahim El-battrawyFabiana RomeoFrancesca GuastafierroSalvatore NovoHolger ThieleChristian MöllerFrancesco SantoroAlessandro Capucci

subject

Pulmonary and Respiratory Medicinemedicine.medical_specialtyEjection fractionbusiness.industryCardiogenic shockIncidence (epidemiology)Hazard ratioCritical Care and Intensive Care Medicinemedicine.diseasePulmonary edemaClinical trial03 medical and health sciences0302 clinical medicine030228 respiratory systemInterquartile rangeInternal medicineCohortmedicineCardiology030212 general & internal medicineCardiology and Cardiovascular Medicinebusiness

description

Background The short- and long-term prognosis of Takotsubo syndrome (TTS) presenting with right ventricular (RV) involvement remains poorly understood. Research Question What is the incidence and clinical outcome of RV involvement in TTS? Study Design and Methods This study analyzed 839 consecutive patients with TTS (758 female subjects and 81 male subjects) in a multicenter registry. RV involvement was defined as wall motion abnormality of the RV free wall, with or without apical involvement. The median long-term follow-up was 2.1 years (interquartile range, 0.3-4.5 years). The primary outcome was in-hospital and out-of-hospital all-cause mortality. The secondary end point was a composite of in-hospital death, thromboembolic events, cardiogenic shock, pulmonary edema, and malignant arrhythmias. Results The incidence of RV involvement in TTS was 11% (n = 93). More often patients with RV involvement were male compared with patients without RV involvement (P = .02). There was a slight difference in the left ventricular ejection fraction measured in patients with RV involvement vs those patients with isolated left ventricular TTS (38 ± 10% vs 40 ± 10%; P = .03). No major differences in terms of comorbidities were observed between groups except regarding a history of cancer, which was significantly more prevalent in patients with TTS presenting with RV involvement (P = .03). Physical stressors were more prevalent in the RV group (P  Interpretation RV involvement defines a high-risk cohort of patients with TTS. Clinical Trial Registration ClinicalTrials.gov ; No.: NCT04361994 ; URL: www.clinicaltrials.gov .

https://doi.org/10.1016/j.chest.2021.04.072